MarketInOut Stock Screener Log In | Sign Up
 

TherapeuticsMD Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026
TherapeuticsMD Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization20.83 mln
Float10.60 mln
Earnings Date11/12/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.63
Likely reliable

Relative Strength

21 / 100
Significantly lagging

Debt / Equity

0.21
Very low leverage

Pre-Tax Margin

-8%
Marginally loss-making

ROE

-0.80
Negative

Business Description

TherapeuticsMD Inc. is a U.S.-based pharmaceutical royalty company founded in 2008 and headquartered in Boca Raton, Florida. The company earns revenue through a licensing agreement with Mayne Pharma, which handles the sale and distribution of several branded prescription and prenatal vitamin products on its behalf. These products reach patients through wholesale and retail pharmacy channels across the country.

Key Fundamentals

EPS-0.04
ROE-0.80
RPS0.28
ROIC-12.99
ROA-0.57
Interest Cover-963
EBITDA, mln1.40
EV / EBITDA14.33
EV / EBIT-77.28
Revenue, mln3.27
EV / Revenue6.12

Quote Details

Last 1.80
Change -0.05 (-2.7%)
Open 1.87
Volume 15,702
Turnover 28,264
Average Volume 20,300

Financial Ratios

Pre-Tax Profit Margin-8
Leverage Ratio1.38
Current Ratio2.76
Price / Book0.87
Price / Tangible Book1.00
Price / Cash Flow6.68
Price / Free Cash Flow7.59
Debt / Equity0.21
Price / Sales7.18

Financial Strength

Altman Z-Score-33.81
Piotroski F-Score 6 / 9
Beneish M-Score-2.63
Short Ratio1.15
Short % of Float0.28

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.26% 16 / 100   
1 Month -15.49% 22 / 100   
2 Months -14.69% 27 / 100   
6 Months -17.81% 28 / 100   
1 Year 47.54% 91 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog